FindTrial
Sign In

Exploring the clinical value of Xuebijing in the treatment of sepsis based on real world data

Exploring the clinical value of Xuebijing in the treatment of sepsis based on real world data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025523
Enrollment
Unknown
Registered
2019-08-31
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Experimental group:Use Xuebijing

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged >=18 years; 2. patients with sepsis; 3. less or less than 20% of clinical data.

Exclusion criteria

Exclusion criteria: 1. Those who did not meet the criteria for inclusion of the disease; 2. patients with severe mental illness; 3. the diagnosis, course of disease, medical order, examination, treatment, combined medication, cost and other major medical information missing rate >=20%; 4. used other traditional Chinese medicine injections.

Design outcomes

Primary

MeasureTime frame
Survival rate;—

Countries

China

Contacts

Public ContactQingping Shi

The First Affiliated Hospital of Bengbu Medical College

sir_shi@126.com+86 13855288331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026